Trial Profile
A pilot study of Iodine in patients with cyclic breast pain associated with symptomatic fibrocystic breast condition
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Iodine (Primary)
- Indications Breast pain; Fibrocystic breast disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors BioPharmX Corporation; Trex Wind-down
- 15 Feb 2024 According to Timber Pharmaceuticals media release, Timber Pharmaceuticals has changed its name to Trex Wind-down
- 16 May 2016 According to an BioPharmX Corporation media release, information about this trial presented at American Congress of Obstetricians and Gynecologists (ACOG)
- 22 Jan 2016 New trial record